VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DLHCDLH Holdings Corp.
$5.26$76M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksDLHCFinancials

DLH Holdings Corp. (DLHC) Financials

30Y historyFree accessUpdated daily

Operating performance has deteriorated significantly, with revenue contracting 33.6% in 2026Q2 and operating margins falling to -0.1% from a 7.0% peak in 2024Q1.

DLHC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97Sep'96
Sales/Revenue292.66M344.5M395.94M375.87M395.17M246.09M209.19M160.39M133.24M115.66M85.6M65.35M60.49M53.51M49.19M41.92M40.87M46.02M73.28M66.88M71.64M47.27M32.86M62.8M798.21M649.73M447.74M244.8M139.4M122.6M100.9M
Revenue Growth %-22.39%-12.99%5.34%-4.88%60.58%17.64%30.42%20.38%15.19%35.12%31%8.02%13.06%8.77%17.34%2.57%-11.18%-37.2%9.57%-6.65%51.55%43.89%-47.69%-92.13%22.85%45.11%82.9%75.61%13.7%21.51%36.72%
Cost of Goods Sold191.14M279.33M318.45M296.02M322.89M194.61M163.6M124.55M105.37M89.81M67.78M53.66M51.53M46.01M43.6M36.02M36.07M39.02M61.22M55.85M59.86M39.05M26.88M50.62M63.8M621.63M426.99M228.3M129.7M113.9M92.5M
COGS % of Revenue-81.08%80.43%78.75%81.71%79.08%78.21%77.65%79.09%77.65%79.18%82.11%85.19%85.98%88.62%85.93%88.24%84.79%83.54%83.51%83.55%82.61%81.81%80.59%7.99%95.68%95.36%93.26%93.04%92.9%91.67%
Gross Profit42.26M65.16M77.49M79.86M72.29M51.48M45.59M35.84M27.86M25.85M17.83M11.69M8.96M7.5M5.6M5.9M4.81M7M12.06M11.03M11.79M8.22M5.98M12.19M734.41M28.1M20.76M16.5M9.7M8.7M8.4M
Gross Margin %14.44%18.92%19.57%21.25%18.29%20.92%21.79%22.35%20.91%22.35%20.82%17.89%14.81%14.02%11.38%14.07%11.76%15.21%16.46%16.49%16.45%17.39%18.19%19.41%92.01%4.32%4.64%6.74%6.96%7.1%8.33%
Gross Profit Growth %--15.91%-2.96%10.47%40.42%12.92%27.2%28.63%7.78%45.01%52.52%30.46%19.47%33.98%-5.1%22.7%-31.35%-41.95%9.35%-6.41%43.34%37.58%-50.98%-98.34%2513.83%35.37%25.79%70.1%11.49%3.57%55.56%
Operating Expenses42.32M48.38M52.59M62.77M39.01M34.26M32.13M25.87M19.08M19.22M13.76M9.19M8.2M7.25M7.75M10.12M9.14M6.62M11.34M13.06M14.19M13.18M10.6M14.92M730.67M24.82M18.34M13.3M8.1M11.3M8.8M
OpEx % of Revenue-14.04%13.28%16.7%9.87%13.92%15.36%16.13%14.32%16.62%16.08%14.07%13.55%13.55%15.75%24.14%22.37%14.38%15.47%19.53%19.81%27.88%32.26%23.76%91.54%3.82%4.1%5.43%5.81%9.22%8.72%
Selling, General & Admin29.41M31.2M35.54M37.8M30.73M25.05M24.2M20.52M16.84M17.47M12.52M9.14M8.09M7.13M7.36M7.42M7.68M6.5M11.03M12.71M13.81M12.76M10.26M14.59M12.09M23.39M17M12.2M7.4M10.3M8M
SG&A % of Revenue-9.06%8.98%10.06%7.78%10.18%11.57%12.8%12.64%15.1%14.62%13.98%13.37%13.33%14.96%17.71%18.8%14.13%15.05%19.01%19.28%26.99%31.22%23.24%1.51%3.6%3.8%4.98%5.31%8.4%7.93%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses3M17.18M17.05M24.97M8.28M9.2M7.93M5.35M2.24M1.75M1.24M55K106K121K387K2.7M1.46M111K311K349K381K422K342K329K718.58M1.42M1.33M1.1M700K1M800K
Operating Income7.42M16.79M24.9M17.09M33.28M17.22M13.46M9.97M8.78M6.63M4.06M2.5M764K248K-2.15M-4.22M-4.34M386K721K-2.03M-2.41M-4.96M-4.62M-2.73M3.74M3.28M2.42M3.2M1.6M-2.6M-400K
Operating Margin %2.53%4.87%6.29%4.55%8.42%7%6.44%6.21%6.59%5.73%4.75%3.82%1.26%0.46%-4.37%-10.07%-10.61%0.84%0.98%-3.04%-3.36%-10.49%-14.07%-4.35%0.47%0.5%0.54%1.31%1.15%-2.12%-0.4%
Operating Income Growth %--32.59%45.69%-48.64%93.22%27.95%35.04%13.5%32.46%63.14%62.82%226.7%208.06%111.53%49.06%2.63%-1223.58%-46.46%135.46%15.57%51.43%-7.22%-69.19%-173.06%14.12%35.57%-24.44%100%161.54%-550%81.82%
EBITDA24.62M33.97M41.95M32.65M40.94M25.34M20.46M13.92M11.02M8.35M5.31M2.55M880K547K-1.88M-4.08M-4.22M497K1.03M-1.68M-2.03M-4.54M-4.25M-1.79M4M4.7M3.75M4.3M2.3M-1.6M400K
EBITDA Margin %8.41%9.86%10.6%8.69%10.36%10.3%9.78%8.68%8.27%7.22%6.2%3.9%1.45%1.02%-3.81%-9.72%-10.32%1.08%1.41%-2.52%-2.83%-9.59%-12.95%-2.85%0.5%0.72%0.84%1.76%1.65%-1.31%0.4%
EBITDA Growth %-38.47%-19.04%28.48%-20.25%61.59%23.82%46.97%26.31%31.96%57.39%108.08%189.89%60.88%129.16%53.99%3.37%-948.89%-51.84%161.28%16.92%55.31%-6.6%-137.44%-144.83%-14.99%25.35%-12.77%86.96%243.75%-500%130.77%
D&A (Non-Cash Add-back)17.21M17.18M17.05M15.56M7.67M8.12M7M3.96M2.24M1.72M1.24M55K116K299K275K146K118K111K311K349K381K422K369K941K256K1.42M1.33M1.1M700K1M800K
EBIT6.24M15.12M23.1M14.97M32.64M16.43M12.86M9.01M8.47M6.29M2.9M2.5M764K248K-1.88M-4.3M-4.42M570K939K-547K-2.41M-4.96M-4.62M-2.73M722.13M3.28M2.42M3.2M1.6M-2.6M-400K
Net Interest Income-13.56M-15.03M-17.15M-16.27M-2.21M-3.78M-3.56M-2.49M-1.07M-1.15M-743K-80K-109K-349K-480K-283K-161K-177K-119K-123K-463K-163K-43K00000000
Interest Income58K71K38K0000000000013K8K13K45K40K74K76K48K38K00000000
Interest Expense13.62M15.1M17.19M16.27M2.21M3.78M3.56M2.49M1.07M1.15M743K80K109K349K493K291K174K222K159K197K539K211K81K00000000
Other Income/Expense-13.56M-15.03M-17.15M-16.27M-2.21M-3.78M-3.44M-2.47M-1.12M-1.23M-1.62M744K-4K-407K125K-367K-261K-38K527K-1.46M-303K17K189K381K950K-315K-1.04M-600K-200K2.6M400K
Pretax Income-6.14M1.75M7.75M820K31.06M13.44M10.02M7.5M7.67M5.4M2.45M3.24M760K-159K-2.03M-4.59M-4.6M348K1.25M-3.5M-2.71M-4.94M-4.43M-2.35M4.69M2.96M1.38M2.6M1.4M00
Pretax Margin %-2.1%0.51%1.96%0.22%7.86%5.46%4.79%4.67%5.75%4.67%2.86%4.96%1.26%-0.3%-4.12%-10.95%-11.25%0.76%1.7%-5.23%-3.78%-10.45%-13.5%-3.74%0.59%0.46%0.31%1.06%1%--
Income Tax-1.65M393K350K-641K7.78M3.29M2.91M2.17M5.83M2.11M-938K-5.49M-4.6M0000-28K60K-123K15.83M-1.88M-1.69M-861K1.72M1.26M428K800K-1.3M00
Effective Tax Rate %26.9%22.39%4.52%-78.17%25.03%24.51%29%28.97%76.05%39.13%-38.35%-169.38%-604.87%0%0%0%0%-8.05%4.81%3.52%-583.77%37.97%38.02%36.61%36.6%42.56%31.04%30.77%-92.86%--
Net Income-4.49M1.36M7.4M1.46M23.29M10.14M7.11M5.32M1.84M3.29M3.38M8.73M5.36M-159K-2.03M-4.32M-5.81M-4.36M1.15M-4.69M-31.78M-5.55M-4.08M-28.89M3.08M1.35M951K1.8M2.7M-2.8M-600K
Net Margin %-1.53%0.4%1.87%0.39%5.89%4.12%3.4%3.32%1.38%2.84%3.95%13.36%8.86%-0.3%-4.12%-10.3%-14.21%-9.46%1.56%-7.02%-44.36%-11.75%-12.41%-45.99%0.39%0.21%0.21%0.74%1.94%-2.28%-0.59%
Net Income Growth %-182.72%-81.59%406.3%-93.73%129.55%42.61%33.62%189.98%-44.16%-2.84%-61.23%62.93%3469.18%92.15%53.1%25.61%-33.34%-480.02%124.42%85.23%-472.27%-36.16%85.88%-1039.35%128.12%41.75%-47.17%-33.33%196.43%-366.67%81.82%
Net Income (Continuing)-4.49M1.36M7.4M1.46M23.29M10.14M7.11M5.32M1.84M3.29M3.38M8.73M5.36M-159K-2.03M-4.59M-4.6M376K1.19M-3.37M-18.54M-3.06M-2.75M-1.49M2.97M1.7M951K1.8M2.7M-2.8M-600K
Discontinued Operations000000000000000270K-1.21M-4.73M-42K-1.32M-13.25M-2.49M-1.33M-27.39M101K000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)-0.310.090.510.101.640.750.540.410.140.270.300.870.54-0.02-0.14-0.30-0.40-0.300.08-0.42-0.69-0.14-1.02-7.230.750.600.470.991.93-2.09-0.55
EPS Growth %-184.28%-81.53%410%-93.9%118.67%38.89%31.71%192.86%-48.15%-10%-65.52%61.11%3257.89%87.79%53.33%25%-33.33%-479.75%118.81%39.13%-392.86%86.27%85.89%-1064%25%27.66%-52.53%-48.7%192.34%-280%83.53%
EPS (Basic)-0.090.520.111.820.810.580.440.140.290.340.910.56-0.02-0.14-0.30-0.40-0.300.08-0.42-0.69-0.14-1.02-7.240.750.630.470.991.93-2.09-0.55
Diluted Shares Outstanding14.39M14.46M14.4M14.43M14.18M13.6M13.11M13.04M12.87M12.35M11.22M10.04M9.99M9.31M14.5M14.5M14.5M14.5M14.5M19.29M19.28M18.21M3.99M3.99M4.11M2.26M2.03M1.81M1.41M1.34M1.09M
Basic Shares Outstanding14.39M14.39M14.17M13.7M12.83M12.55M12.28M12.02M12.87M11.35M9.97M9.57M9.71M9.31M14.46M14.46M14.46M14.46M14.46M19.29M19.28M18.21M3.99M3.99M4.06M2.21M2.02M1.81M1.4M1.34M1.09M
Dividend Payout Ratio-------------------------------

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowDeteriorating
Top Statement Risk

Federal contract recompete exposure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Persistent Revenue Contraction Trends

As indicated by the most recent quarterly financial data, DLHC has experienced a significant revenue decline, with the top line contracting by 33.6% in 2026Q2 compared to the prior year, signaling a potential loss of critical federal contract volume or delays in new program awards.

The consistent downward trajectory in revenue over the last ten quarters suggests that the company is struggling to replace expiring contract vehicles with new wins. This trend warrants close investigation into the company's book-to-bill ratio, as the current inability to maintain top-line stability may indicate a weakening competitive position within its core federal health segments.

Structural Margin Erosion Under Pressure

According to the reported income statement figures, DLHC's gross margin has faced significant volatility, culminating in a complete lack of reported gross profit in 2026Q2, which highlights the fragility of the company's cost-plus and fixed-price contract model in the face of declining scale.

The erosion of margins suggests that the company is failing to absorb fixed overhead costs as revenue volumes shrink. Investors should monitor whether this margin compression is a temporary byproduct of contract transitions or a permanent shift in the profitability profile of the firm's service offerings.

Operating Leverage Turning Into Liability

Based on the provided financial statements, DLHC's operating income has deteriorated from a peak of $6.8 million in 2024Q1 to a loss of $55,000 in 2026Q2, demonstrating that the company lacks the necessary scale to maintain positive operating leverage during periods of revenue contraction.

The inability to scale SG&A expenses downward in proportion to the revenue decline suggests a rigid cost structure that may be difficult to optimize in the short term. This lack of operating flexibility appears to be a primary driver of the company's recent net losses and warrants further scrutiny regarding management's expense discipline.

Earnings Quality Obscured by Losses

As reported in recent filings, DLHC's net income has shifted into negative territory, with a net loss of $2.5 million in 2026Q2, suggesting that non-operating items and interest expenses are exacerbating the impact of the company's core operational challenges on the bottom line.

The transition from profitability to consistent net losses indicates that the company's earnings quality is currently poor, with little room for error in its financial performance. The presence of stock-based compensation alongside these losses suggests that shareholder dilution may be occurring without the benefit of underlying earnings growth.

Sustainability of Current Business Model

Based on the reported figures, the company's extremely low cash position of $125,000 combined with a 33.6% revenue decline raises significant questions regarding the sustainability of its current operations and its ability to fund ongoing contract requirements without additional capital or credit facility access.

Short-term observers may focus on the potential for a liquidity crisis if the company cannot stabilize its revenue base or secure additional funding. The current financial profile suggests that the company is operating with minimal margin for error, making it highly susceptible to any further delays in federal funding or contract losses.

DLHC — Frequently Asked Questions

Quick answers to the most common questions about buying DLHC stock.

What was DLH Holdings Corp.'s (DLHC) revenue in 2025?

For fiscal year 2025, DLH Holdings Corp. (DLHC) reported total revenue of $344.5M. This represents a 241.4% increase compared to $100.9M in 1996.

Is DLH Holdings Corp. (DLHC) profitable?

DLH Holdings Corp. (DLHC) is profitable, generating $1.4M in net income for the fiscal year ending 2025 with a net profit margin of 0.4%.

What is DLH Holdings Corp.'s operating profit margin?

DLH Holdings Corp. (DLHC) reported an operating income of $16.8M, resulting in an operating profit margin of 4.9%. This margin reflects the operational efficiency of the business before interest and taxes.

What is DLH Holdings Corp.'s gross profit and gross margin?

DLH Holdings Corp. (DLHC) generated $65.2M in gross profit for the year, representing a gross profit margin of 18.9%. This demonstrates the company's core pricing power and production efficiency.